Perimetrics Intellectual Property

Perimetrics holds 79 global patents protecting the core technology behind QPD and the InnerView® platform. This portfolio reflects over a decade of innovation and secures the proprietary methods that make internal mobility measurement possible.

Patents & Patent Families

P-P1002 Patent Family (1)

This patent family addresses the InnerView^® system and a variety of methods for using it for measuring the structural characteristics of different types of specimens, such as honeycomb structures, prosthetic dental implants, teeth and others...

P-P1003 Patent Family (2-3)

This patent family addresses methods of using the InnerView^® system for assessing bone density of a specimen, such as the bone into which an object such as a tooth, dental or other implant is anchored...

P-P1004 Patent Family (4-13)

This patent family addresses the InnerView™ device, system and methods for non-destructive measurement of structural characteristics of an object, such as anatomical structures (e.g. teeth), physical or industrial structures (e.g. materials and structures in buildings, machines, constructions, etc.) via a reciprocating energy application tool (e.g. tapping rod)...

P-P1005PC01 Patent Family (14-24)

This patent family addresses the InnerView^® device and system for measurement of structural characteristics of an object, such as anatomical structures (e.g. teeth), physical or industrial structures (e.g. materials and structures in buildings, machines, constructions, etc.) via a reciprocating energy application tool (e.g. tapping rod)...

P-P1005PC02 Patent Family (25-45)

This patent family addresses a variety of features for the InnerView^® device including a hollow disposable feature which separates the energy application tool from the object during use, such as to reduce cross-contamination or the need to clean the device between uses; a hollow disposable feature which may extend toward the surface of the object to aid in accommodating irregular surfaces...

P-P1005PC03 Patent Family (46-59)

This patent family addresses a number of enhanced features for the InnerView^® device including features, operational controls and components for operating the InnerView^® device at varying orientations or inclinations relative to the horizontal (e.g. +/- 45°), including by modulating the energy application process to mimic a substantially horizontal position during measurement...

P-P1005PC04 Patent Family (60-63)

This patent family addresses a number of enhanced features for the InnerView^® device including features and operational controls for operating the InnerView^® device based on characteristics of the object being measured, including object type, shape/geometry, size, surface area, density, dimensions, surrounding environment, position...

P-P1006 Patent Family (64-66)

This patent family addresses a number of enhanced operational methods for the InnerView^® system including computational and analytical methods such as (i) using compilations of test results, such as those collected from the same object or different test objects; (ii) using annotations and/or validations of test results; (iii) generating and using predictive models, such as by...

P-P1007 Patent Family (67-76)

This patent family addresses advanced operational features, methods and systems for the InnerView^® system including (i) utilization of advanced machine learning and artificial intelligence methods and systems to analyze complex signals, such as those generated by the energy return from measurements with the InnerView^® device on an object, such as for separating...

P-P1005USD Patent Family (77-78)

This patent family addresses the aesthetic design features of the InnerView® device, including the handpiece and separate disposable tip.

Global Patent Coverage: Core Technologies Behind the InnerView® System

Perimetrics holds a robust portfolio of 10 patent families supporting the InnerView system. These patents form the foundation of the system’s functional capabilities—from signal analysis and data tracking to hygiene-safe design. With protection across the U.S. and international jurisdictions, this portfolio reflects both innovation and clinical application. Each listing includes status transparency to support regulatory clarity, technical due diligence, and clinical trust.

Patent No.	Application No.	Patent Family	Jurisdictions	Status	Function
6997887	10/671002	P-P1002	US	Granted	Damping measurement
6997887	10/671002	P-P1002	US/EPO	Pending	Damping measurement
7008385	10/802117	P-P1003	US	Granted	Bone density measurement
EP1677695B1	EP11188989A	P-P1003	EPO	Granted	Bone density measurement
AU2011268093B2	AU2011268093A	P-P1004	Australia	Granted	Structural measurement
CA2802961C	CA2802961A1	P-P1004	Canada	Granted	Structural measurement
CN103025238B	CN103025238A	P-P1004	China (PRC)	Granted	Structural measurement
EP3235440B1	EP3235440A1	P-P1004	EPO	Granted	Structural measurement
EP2603143B1	EP2603143A2	P-P1004	EPO	Granted	Structural measurement
JP5941911B2	EP2603143A2	P-P1004	Japan	Granted	Structural measurement
JP5956703B1	JP2016171999A	P-P1002	Japan	Granted	Structural measurement
10488312	15/150194	P-P1004	US	Pending	Structural measurement
9869606	13/716140	P-P1005PC01	US	Granted	Device stabilization
AU2012351969B2	AU2012351969A1	P-P1005PC01	Australia	Granted	Device stabilization
CA2859589C	CA2859589A1	P-P1005PC01	Canada	Granted	Device stabilization
CN109259803B	CN109259803A	P-P1005PC01	China (PRC)	Granted	Device stabilization
EP3505900B1	EP3505900A1	P-P1005PC01	EPO	Granted	Device stabilization
EP2791642B1	EP2791642A1	P-P1005PC01	EPO	Granted	Device stabilization
JP6457618B2	JP2018054627A	P-P1005PC01	Japan	Granted	Device stabilization
JP6250767B2	JP2017049261A	P-P1005PC01	Japan	Granted	Device stabilization
JP6028040B2	JP2015501942A	P-P1005PC01	Japan	Granted	Device stabilization
11604115	15/852191	P-P1005PC01	US	Granted	Device stabilization
–	18/121132	P1005PC01	US	Pending	Bone density measurement
11493415	16/475101	P-P1005PC02	US	Granted	Disposable + sensor design
–	AU2022291554A	P-P1005PC02	Australia	Pending	Disposable + sensor design
AU2017388999C1	AU2017388999A	P-P1005PC02	Australia	Granted	Disposable + sensor design
BR112019013572B1	BR112019013572	P-P1005PC02	Brazil	Granted	Disposable + sensor design
–	CA3048985A1	P-P1005PC02	Canada	Pending	Disposable + sensor design
–	CN118329356A	P-P1005PC02	China (PRC)	Pending	Disposable + sensor design
–	CN110139625A	P-P1005PC02	China (PRC)	Pending	Disposable + sensor design
–	CN117629558A	P-P1005PC02	China (PRC)	Pending	Disposable + sensor design
–	EP3562429A1	P-P1005PC02	EPO	Pending	Disposable + sensor design
IN465767	201927030593	P-P1005PC02	India	Granted	Disposable + sensor design
–	JP2024054116A	P-P1005PC02	Japan	Pending	Disposable + sensor design
JP7422475B2	JP2022180540A	P-P1005PC02	Japan	Granted	Disposable + sensor design
JP7148520B2	JP2020515814A	P-P1005PC02	Japan	Granted	Disposable + sensor design
MY204341A	PI2019003754	P-P1005PC02	Malaysia	Granted	Disposable + sensor design
–	MX2024009351A	P-P1005PC02	Mexico	Pending	Disposable + sensor design
–	MX2019007883A	P-P1005PC02	Mexico	Pending	Disposable + sensor design
KR102327863B1	KR20200142602A	P-P1005PC02	South Korea	Granted	Disposable + sensor design
TWI782026B	TW201929788A	P-P1005PC02	Taiwan (ROC)	Granted	Disposable + sensor design
TWI806791B	TW202308553A	P-P1005PC02	Taiwan (ROC)	Granted	Disposable + sensor design
11906484	17/952539	P-P1005PC02	US	Granted	Disposable + sensor design
–	18/581703	P-P1005PC02	US	Pending	Disposable + sensor design
–	16/959406	P-P1005PC03	US	Pending	Energy control features
AU2018395057C1	AU2018395057A	P-P1005PC03	Australia	Granted	Energy control features
–	CA3087068A1	P-P1005PC03	Canada	Pending	Energy control features
–	CN111527393A	P-P1005PC03	China (PRC)	Pending	Energy control features
–	EP4354112A2	P1005PC03	EPO	Pending	Energy control features
EP3732463B1	EP3732463A1	P-P1005PC03	EPO	Granted	Energy control features
–	JP2024059870A	P-P1005PC03	Japan	Pending	Energy control features
IN486008	202027032543	P-P1005PC03	India	Granted	Energy control features
JP7447001B2	JP2021509176A	P-P1005PC03	Japan	Granted	Energy control features
–	MX2024010367A	P-P1005PC03	Mexico	Pending	Energy control features
–	MX2020006928A	P1005PC03	Mexico	Pending	Energy control features
KR102593814B1	KR1020207012906A	P-P1005PC03	South Korea	Granted	Energy control features
–	19/031550	P-P1005PC03	US	Pending	Energy control features
–	031558	P-P1005PC03	Mexico	Pending	Energy control features
–	17/623014	P-P1005PC04	US	Pending	Object-specific controls
EP3990886B1	EP3990886A1	P-P1005PC04	EPO	Granted	Object-specific controls
–	BR112019013572	P-P1005PC04	Brazil	Pending	Object-specific controls
–	CN114072659A	P-P1005PC04	China (PRC)	Pending	Object-specific controls
12082940	16/731020	P-P1006	US	Granted	Predictive modeling
11488062	16/731015	P-P1006	US	Granted	Predictive modeling
–	17/978361	P-P1006	US	Pending	Predictive modeling
–	18/812535	P-P1007	US	Pending	AI signal analysis
–	18/812535	AU23224292A	Australia	Pending	AI signal analysis
–	BR1120240172406A2	P-P1007	Brazil	Pending	AI signal analysis
–	CA3244042	P-P1007	Canada	Pending	AI signal analysis
–	CN202380034583.7	P-P1007	China (PRC)	Pending	AI signal analysis
–	EP44823782A2	P-P1007	EPO	Pending	AI signal analysis
–	JP2024-550219	P-P1007	Japan	Pending	AI signal analysis
–	MX2024010435A	P-P1007	Mexico	Pending	AI signal analysis
–	KR20240154577A	P-P1007	South Korea	Pending	AI signal analysis
–	63/486960	P-P1007	US	Pending	AI signal analysis
D850618	29/589452	P-P1005USD	US	Design Patent	Aesthetic design
D821580	29/589452	P-P1005USD	US	Design Patent	Aesthetic design

How Our Patented Technology Performs in Real Cases

The technology behind the InnerView system has been validated in a 10-year, IRB-approved clinical study across 264 test sites, demonstrating over 90% sensitivity in detecting structural damage. But its greatest impact is in everyday use—where it helps clinicians intervene earlier, with greater clarity and confidence.

In this case study, Dr. Cherilyn Sheets used the InnerView® system to evaluate a 90-year-old patient with severe wear. Trendline data revealed progressive micromobility in Tooth 29—despite no symptoms—prompting timely intervention and confirming damage upon preparation.

See how structural risk was identified before symptoms appeared.